Our exploratory study shows that IDO1 tumour expression is mainly correlated with inflammatory (blood) markers and TDO2 expression predominantly with patient characteristics such as age, gender, smoking habit and medication use in newly diagnosed GBM patients. Here, IDO1 is linked to glioblastoma.